2014 Journal Article Elevated metal concentrations in the CF airway correlate with cellular injury and disease severitySmith, Daniel J., Anderson, Gregory J., Bell, Scott C. and Reid, David W. (2014). Elevated metal concentrations in the CF airway correlate with cellular injury and disease severity. Journal of Cystic Fibrosis, 13 (3), 289-295. doi: 10.1016/j.jcf.2013.12.001 |
2014 Journal Article Molecular imprint of exposure to naturally occurring genetic variants of human cytomegalovirus on the T cell repertoireSmith, Corey, Gras, Stephanie, Brennan, Rebekah M., Bird, Nicola L., Valkenburg, Sophie A., Twist, Kelly-Anne, Burrows, Jacqueline M., Miles, John J., Chambers, Daniel, Bell, Scott, Campbell, Scott, Kedzierska, Katherine, Burrows, Scott R., Rossjohn, Jamie and Khanna, Rajiv (2014). Molecular imprint of exposure to naturally occurring genetic variants of human cytomegalovirus on the T cell repertoire. Scientific Reports, 4 (1) 3993, 3993.1-3993.10. doi: 10.1038/srep03993 |
2014 Conference Publication Evidence of Cross-Transmission of a Multidrug Resistant (Mdr) Pseudomonas Aeruginosa Strain in Patient with Cystic Fibrosis (Cf)Tai, A., Kidd, T., Ramsay, K., Bell, S. and Whiley, D. (2014). Evidence of Cross-Transmission of a Multidrug Resistant (Mdr) Pseudomonas Aeruginosa Strain in Patient with Cystic Fibrosis (Cf). Annual Scientific Meeting of the Thoracic Society of Australia and New Zealand and the Australian and New Zealand Society of Respiratory Science 2014, Adelaide, SA Australia, 4-9 April 2014. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/resp.12263_10 |
2014 Journal Article Pregnancy and cystic fibrosis: approach to contemporary managementGeake, James, Tay, George, Callaway, Leonie and Bell, Scott C. (2014). Pregnancy and cystic fibrosis: approach to contemporary management. Obstetric Medicine, 7 (4), 147-155. doi: 10.1177/1753495X14554022 |
2014 Journal Article A CFTR corrector (lumacaftor) and a CFTR potentiator (ivacaftor) for treatment of patients with cystic fibrosis who have a phe508del CFTR mutation: A phase 2 randomised controlled trialBoyle, Michael P., Bell, Scott C., Konstan, Michael W., McColley, Susanna A., Rowe, Steven M., Rietschel, Ernst, Huang, Xiaohong, Waltz, David, Patel, Naimish R. and Rodman, David (2014). A CFTR corrector (lumacaftor) and a CFTR potentiator (ivacaftor) for treatment of patients with cystic fibrosis who have a phe508del CFTR mutation: A phase 2 randomised controlled trial. The Lancet Respiratory Medicine, 2 (7), 527-538. doi: 10.1016/S2213-2600(14)70132-8 |
2014 Conference Publication Spreading the Word: Introducing Pre-Service Teachers to Programming in the K-12 ClassroomBell, Scott, Frey, Tim and Vasserman, Eugene (2014). Spreading the Word: Introducing Pre-Service Teachers to Programming in the K-12 Classroom. 45th ACM SIGCSE Technical Symposium on Computer Science Education (SIGCSE), Atlanta Ga, Mar 05-08, 2014. NEW YORK: ASSOC COMPUTING MACHINERY. doi: 10.1145/2538862.2538963 |
2014 Journal Article Challenges of providing care to adults with cystic fibrosisBell, Scott C. and Reid, David W. (2014). Challenges of providing care to adults with cystic fibrosis. European Respiratory Monograph, 64 (64), 286-303. doi: 10.1183/1025448x.10010513 |
2014 Conference Publication The Effect of Ivacaftor in Individuals with Cystic Fibrosis and Severe Lung Disease: Analysis of Data From the Australian Named Patient ProgrammeWainwright, C., Bell, S., Morton, J., Ryan, G., Serisier, D., Bye, P., Mulrennan, S., Daley, C. and Greville, H. (2014). The Effect of Ivacaftor in Individuals with Cystic Fibrosis and Severe Lung Disease: Analysis of Data From the Australian Named Patient Programme. Annual Scientific Meeting of the Thoracic Society of Australia and New Zealand and the Australian and New Zealand Society of Respiratory Science 2014, Adelaide, SA Australia, 4-9 April 2014. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/resp.12263_10 |
2013 Journal Article Factors influencing acquisition of Burkholderia cepacia complex organisms in patients with cystic fibrosisRamsay, Kay A., Butler, Claire A., Paynter, Stuart, Ware, Robert S., Kidd, Timothy J., Wainwright, Claire E. and Bell, Scott C. (2013). Factors influencing acquisition of Burkholderia cepacia complex organisms in patients with cystic fibrosis. Journal of Clinical Microbiology, 51 (12), 3975-3980. doi: 10.1128/JCM.01360-13 |
2013 Journal Article Ivacaftor in severe cystic fibrosis lung disease and a G551D mutationWood, Michelle E., Smith, Daniel J., Reid, David W., Masel, Philip J., France, Megan W. and Bell, Scott C. (2013). Ivacaftor in severe cystic fibrosis lung disease and a G551D mutation. Respirology Case Reports, 1 (2), 52-54. doi: 10.1002/rcr2.27 |
2013 Journal Article Change in the executive editorial team at JCFBell, Scott, Hartl, Dominik and Heijerman, Harry (2013). Change in the executive editorial team at JCF. Journal of Cystic Fibrosis, 12 (6), 545-546. doi: 10.1016/j.jcf.2013.10.006 |
2013 Journal Article Within-host evolution of Burkholderia pseudomallei over a twelve-year chronic carriage infectionPrice E.P., Sarovich D.S., Mayo M., Tuanyok A., Drees K.P., Kaestli M., Beckstrom-Sternberg S.M., Babic-Sternberg J.S., Kidd T.J., Bell S.C., Keim P., Pearson T. and Currie B.J. (2013). Within-host evolution of Burkholderia pseudomallei over a twelve-year chronic carriage infection. mBio, 4 (4) e00388-13, e00388-13.1-e00388-13.11. doi: 10.1128/mBio.00388-13 |
2013 Journal Article ICU outcomes in cystic fibrosis following invasive ventilationReid, David W. and Bell, Scott C. (2013). ICU outcomes in cystic fibrosis following invasive ventilation. Respirology, 18 (4), 585-586. doi: 10.1111/resp.12077 |
2013 Journal Article High-throughput single-nucleotide polymorphism-based typing of shared Pseudomonas aeruginosa strains in cystic fibrosis patients using the Sequenom iPLEX platformSyrmis, Melanie W., Moser, Ralf J., Kidd, Timothy J., Hunt, Priscilla, Ramsay, Kay A., Bell, Scott C., Wainwright, Claire E., Grimwood, Keith, Nissen, Michael D., Sloots, Theo P. and Whiley, David M. (2013). High-throughput single-nucleotide polymorphism-based typing of shared Pseudomonas aeruginosa strains in cystic fibrosis patients using the Sequenom iPLEX platform. Journal of Medical Microbiology, 62 (5), 734-740. doi: 10.1099/jmm.0.055905-0 |
2013 Conference Publication The Social Network in Cystic Fibrosis (Cf) Centre Care and the Risk of Shared Pseudomonas Aeruginosa (Pa) Strain InfectionKidd, T. J., Magalhaes, R. J. Soares, Paynter, S. and Bell, S. C. (2013). The Social Network in Cystic Fibrosis (Cf) Centre Care and the Risk of Shared Pseudomonas Aeruginosa (Pa) Strain Infection. HOBOKEN: WILEY-BLACKWELL. |
2013 Journal Article Management of comorbidities in older patients with cystic fibrosisPlant, Barry J, Goss, Christopher H, Plant, William D and Bell, Scott C (2013). Management of comorbidities in older patients with cystic fibrosis. The Lancet Respiratory Medicine, 1 (2), 164-174. doi: 10.1016/S2213-2600(13)70025-0 |
2013 Journal Article Screening bacterial metabolites for inhibitory effects against Batrachochytrium dendrobatidis using a spectrophotometric assayBell, Sara C., Alford, Ross A., Garland, Stephen, Padilla, Gabriel and Thomas, Annette D. (2013). Screening bacterial metabolites for inhibitory effects against Batrachochytrium dendrobatidis using a spectrophotometric assay. Diseases of Aquatic Organisms, 103 (1), 77-+. doi: 10.3354/dao02560 |
2013 Journal Article Aztreonam for inhalation solution, challenges to drug approval and integration into CF careGoss, Christopher H. and Bell, Scott C. (2013). Aztreonam for inhalation solution, challenges to drug approval and integration into CF care. Journal of Cystic Fibrosis, 12 (2), 99-101. doi: 10.1016/j.jcf.2012.08.006 |
2013 Journal Article Geographical differences in first acquisition of Pseudomonas aeruginosa in cystic fibrosisRanganathan, Sarath C., Skoric, Billy, Ramsay, Kay A., Carzino, Rosemary, Gibson, Anne-Marie, Hart, Emily, Harrison, Jo, Bell, Scott C. and Kidd, Timothy J. (2013). Geographical differences in first acquisition of Pseudomonas aeruginosa in cystic fibrosis. Annals of the American Thoracic Society, 10 (2), 108-114. doi: 10.1513/AnnalsATS.201209-077OC |
2013 Conference Publication Observational Study of the Clinical Effects of Ivacaftor in Patients with Severe Cystic Fibrosis (Cf) Lung DiseaseWood, M. E., Smith, D. J., Reid, D. W. E. C. and Bell, S. C. (2013). Observational Study of the Clinical Effects of Ivacaftor in Patients with Severe Cystic Fibrosis (Cf) Lung Disease. 2013 Annual Scientific Meetings of The Thoracic Society of Australia and New Zealand and the Australian and New Zealand Society of Respiratory Science, Darwin, NT Australia, 22 - 27 March 2013. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/resp.12046 |